Answers are grounded in this paper and cite their sources.
Non-alcoholic fatty liver disease (NAFLD) is fast becoming a major cause of chronic liver disease and has a global prevalence of around 25-30 % (1-3). The pathological spectrum of NAFLD ranges from non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH), to liver brosis, cirrhosis, and hepatocellular carcinoma (4,5). NASH on histopathology is seen as lobular inammation and balloon degeneration . The presence of NAFLD is also associated with an increased risk of extrahepatic complications including the development of cardiovascular disease (CVD) (6,7), extrahepatic malignancy, and even depression (8). The development and progression of NAFLD is also associated with diabetes which is primarily due to underlying insulin resistance (9).
No takes yet. Share an insight, caveat, or question.
Lachhwani et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: